Dr Anthony Fauci, the director of the US National Institute of Allergy and Infectious Diseases (NIAID), has said that three doses of the COVID-19 vaccine are likely to be needed for full protection, CNN reported on Friday.
Dr Fauci cited two Israeli studies that showed a decrease in infections among people who got a third or booster shot. He added that there was good reason to believe that a third dose "will actually be durable, and if it is durable, then you're going to have very likely a three-dose regimen being the routine regimen."
The US Food and Drug Administration (FDA) will consider whether to approve a third dose later this month.
CSL's ANDEMBRY receives European approval to prevent attacks of hereditary angioedema
NICE recommends ALK's ACARIZAX for house dust mite allergic rhinitis treatment in UK's NHS
European Commission approves Palforzia for toddlers with peanut allergy
Eli Lilly and Co receives approval from FDA for Zepbound
CSL gains EMA backing for Garadacimab as HAE prophylactic treatment
Merck initiates Phase 3 trial for LAGEVRIO (molnupiravir)
Allergy Therapeutics reports positive data from VLP Peanut PROTECT trial
CBC Group acquires UCB's mature neurology and allergy business in China
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children